Global Biopharmaceutical Contract Manufacturing(BCMO) Market Growth (Status and Outlook) 2022-2028

January 2022 | 87 pages | ID: G53C6CC54AC2EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Biopharmaceutical Contract Manufacturing(BCMO) will have significant change from previous year. According to our (LP Information) latest study, the global Biopharmaceutical Contract Manufacturing(BCMO) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Biopharmaceutical Contract Manufacturing(BCMO) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Biopharmaceutical Contract Manufacturing(BCMO) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biopharmaceutical Contract Manufacturing(BCMO) market, reaching US$ million by the year 2028. As for the Europe Biopharmaceutical Contract Manufacturing(BCMO) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Biopharmaceutical Contract Manufacturing(BCMO) players cover Lonza Group Ltd, Boehringher Ingelheim, Sandoz, and Fujifilm Diosynth Biotechnology, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Contract Manufacturing(BCMO) market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Mammalian Based Manufacturing
• Microbial Based Manufacturing
• Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Bio-Pharmaceutical Companies
• Pharmaceutical Companies
• Drug Discovery Companies
• Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Lonza Group Ltd
• Boehringher Ingelheim
• Sandoz
• Fujifilm Diosynth Biotechnology
• Rentschler Biotechnologie
• Celonic GmbH
• BIOMEVA GmbH
• ProBioGen AG

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2017-2028
  2.1.2 Biopharmaceutical Contract Manufacturing(BCMO) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Biopharmaceutical Contract Manufacturing(BCMO) Segment by Type
  2.2.1 Mammalian Based Manufacturing
  2.2.2 Microbial Based Manufacturing
  2.2.3 Other
2.3 Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type
  2.3.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Type (2017-2022)
2.4 Biopharmaceutical Contract Manufacturing(BCMO) Segment by Application
  2.4.1 Bio-Pharmaceutical Companies
  2.4.2 Pharmaceutical Companies
  2.4.3 Drug Discovery Companies
  2.4.4 Other
2.5 Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application
  2.5.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application (2017-2022)

3 BIOPHARMACEUTICAL CONTRACT MANUFACTURING(BCMO) MARKET SIZE BY PLAYER

3.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Players
  3.1.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Players (2020-2022)
  3.1.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Players (2020-2022)
3.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BIOPHARMACEUTICAL CONTRACT MANUFACTURING(BCMO) BY REGIONS

4.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions (2017-2022)
4.2 Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth (2017-2022)
4.3 APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth (2017-2022)
4.4 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth (2017-2022)
4.5 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2017-2022)
5.2 Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2017-2022)
5.3 Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2017-2022)
6.2 APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2017-2022)
6.3 APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) by Country (2017-2022)
7.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2017-2022)
7.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) by Region (2017-2022)
8.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2017-2022)
8.3 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BIOPHARMACEUTICAL CONTRACT MANUFACTURING(BCMO) MARKET FORECAST

10.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecast by Regions (2023-2028)
  10.1.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecast by Regions (2023-2028)
  10.1.2 Americas Biopharmaceutical Contract Manufacturing(BCMO) Forecast
  10.1.3 APAC Biopharmaceutical Contract Manufacturing(BCMO) Forecast
  10.1.4 Europe Biopharmaceutical Contract Manufacturing(BCMO) Forecast
  10.1.5 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Forecast
10.2 Americas Biopharmaceutical Contract Manufacturing(BCMO) Forecast by Country (2023-2028)
  10.2.1 United States Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.2.2 Canada Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.2.3 Mexico Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.2.4 Brazil Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
10.3 APAC Biopharmaceutical Contract Manufacturing(BCMO) Forecast by Region (2023-2028)
  10.3.1 China Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.3.2 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.3.3 Korea Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.3.4 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.3.5 India Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.3.6 Australia Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
10.4 Europe Biopharmaceutical Contract Manufacturing(BCMO) Forecast by Country (2023-2028)
  10.4.1 Germany Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.4.2 France Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.4.3 UK Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.4.4 Italy Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.4.5 Russia Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
10.5 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Forecast by Region (2023-2028)
  10.5.1 Egypt Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.5.2 South Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.5.3 Israel Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.5.4 Turkey Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
  10.5.5 GCC Countries Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast
10.6 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecast by Type (2023-2028)
10.7 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Lonza Group Ltd
  11.1.1 Lonza Group Ltd Company Information
  11.1.2 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
  11.1.3 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Lonza Group Ltd Main Business Overview
  11.1.5 Lonza Group Ltd Latest Developments
11.2 Boehringher Ingelheim
  11.2.1 Boehringher Ingelheim Company Information
  11.2.2 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
  11.2.3 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Boehringher Ingelheim Main Business Overview
  11.2.5 Boehringher Ingelheim Latest Developments
11.3 Sandoz
  11.3.1 Sandoz Company Information
  11.3.2 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
  11.3.3 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Sandoz Main Business Overview
  11.3.5 Sandoz Latest Developments
11.4 Fujifilm Diosynth Biotechnology
  11.4.1 Fujifilm Diosynth Biotechnology Company Information
  11.4.2 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
  11.4.3 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Fujifilm Diosynth Biotechnology Main Business Overview
  11.4.5 Fujifilm Diosynth Biotechnology Latest Developments
11.5 Rentschler Biotechnologie
  11.5.1 Rentschler Biotechnologie Company Information
  11.5.2 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
  11.5.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Rentschler Biotechnologie Main Business Overview
  11.5.5 Rentschler Biotechnologie Latest Developments
11.6 Celonic GmbH
  11.6.1 Celonic GmbH Company Information
  11.6.2 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
  11.6.3 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 Celonic GmbH Main Business Overview
  11.6.5 Celonic GmbH Latest Developments
11.7 BIOMEVA GmbH
  11.7.1 BIOMEVA GmbH Company Information
  11.7.2 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
  11.7.3 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 BIOMEVA GmbH Main Business Overview
  11.7.5 BIOMEVA GmbH Latest Developments
11.8 ProBioGen AG
  11.8.1 ProBioGen AG Company Information
  11.8.2 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
  11.8.3 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 ProBioGen AG Main Business Overview
  11.8.5 ProBioGen AG Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biopharmaceutical Contract Manufacturing(BCMO) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Mammalian Based Manufacturing
Table 3. Major Players of Microbial Based Manufacturing
Table 4. Major Players of Other
Table 5. Biopharmaceutical Contract Manufacturing(BCMO) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Type (2017-2022)
Table 8. Biopharmaceutical Contract Manufacturing(BCMO) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application (2017-2022)
Table 11. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Player (2020-2022)
Table 13. Biopharmaceutical Contract Manufacturing(BCMO) Key Players Head office and Products Offered
Table 14. Biopharmaceutical Contract Manufacturing(BCMO) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Regions (2017-2022)
Table 19. Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Country (2017-2022)
Table 21. Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Type (2017-2022)
Table 23. Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application (2017-2022)
Table 25. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Region (2017-2022)
Table 27. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Type (2017-2022)
Table 29. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application (2017-2022)
Table 31. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Country (2017-2022)
Table 33. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Type (2017-2022)
Table 35. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Biopharmaceutical Contract Manufacturing(BCMO)
Table 44. Key Market Challenges & Risks of Biopharmaceutical Contract Manufacturing(BCMO)
Table 45. Key Industry Trends of Biopharmaceutical Contract Manufacturing(BCMO)
Table 46. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share Forecast by Application (2023-2028)
Table 52. Lonza Group Ltd Details, Company Type, Biopharmaceutical Contract Manufacturing(BCMO) Area Served and Its Competitors
Table 53. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
Table 54. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Lonza Group Ltd Main Business
Table 56. Lonza Group Ltd Latest Developments
Table 57. Boehringher Ingelheim Details, Company Type, Biopharmaceutical Contract Manufacturing(BCMO) Area Served and Its Competitors
Table 58. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
Table 59. Boehringher Ingelheim Main Business
Table 60. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Boehringher Ingelheim Latest Developments
Table 62. Sandoz Details, Company Type, Biopharmaceutical Contract Manufacturing(BCMO) Area Served and Its Competitors
Table 63. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
Table 64. Sandoz Main Business
Table 65. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Sandoz Latest Developments
Table 67. Fujifilm Diosynth Biotechnology Details, Company Type, Biopharmaceutical Contract Manufacturing(BCMO) Area Served and Its Competitors
Table 68. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
Table 69. Fujifilm Diosynth Biotechnology Main Business
Table 70. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Fujifilm Diosynth Biotechnology Latest Developments
Table 72. Rentschler Biotechnologie Details, Company Type, Biopharmaceutical Contract Manufacturing(BCMO) Area Served and Its Competitors
Table 73. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
Table 74. Rentschler Biotechnologie Main Business
Table 75. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Rentschler Biotechnologie Latest Developments
Table 77. Celonic GmbH Details, Company Type, Biopharmaceutical Contract Manufacturing(BCMO) Area Served and Its Competitors
Table 78. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
Table 79. Celonic GmbH Main Business
Table 80. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Celonic GmbH Latest Developments
Table 82. BIOMEVA GmbH Details, Company Type, Biopharmaceutical Contract Manufacturing(BCMO) Area Served and Its Competitors
Table 83. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
Table 84. BIOMEVA GmbH Main Business
Table 85. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. BIOMEVA GmbH Latest Developments
Table 87. ProBioGen AG Details, Company Type, Biopharmaceutical Contract Manufacturing(BCMO) Area Served and Its Competitors
Table 88. ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Product Offered
Table 89. ProBioGen AG Main Business
Table 90. ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. ProBioGen AG Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Biopharmaceutical Contract Manufacturing(BCMO) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Type in 2021
Figure 7. Biopharmaceutical Contract Manufacturing(BCMO) in Bio-Pharmaceutical Companies
Figure 8. Global Biopharmaceutical Contract Manufacturing(BCMO) Market: Bio-Pharmaceutical Companies (2017-2022) & ($ Millions)
Figure 9. Biopharmaceutical Contract Manufacturing(BCMO) in Pharmaceutical Companies
Figure 10. Global Biopharmaceutical Contract Manufacturing(BCMO) Market: Pharmaceutical Companies (2017-2022) & ($ Millions)
Figure 11. Biopharmaceutical Contract Manufacturing(BCMO) in Drug Discovery Companies
Figure 12. Global Biopharmaceutical Contract Manufacturing(BCMO) Market: Drug Discovery Companies (2017-2022) & ($ Millions)
Figure 13. Biopharmaceutical Contract Manufacturing(BCMO) in Other
Figure 14. Global Biopharmaceutical Contract Manufacturing(BCMO) Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application in 2021
Figure 16. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Player in 2021
Figure 17. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2017-2022 ($ Millions)
Figure 19. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2017-2022 ($ Millions)
Figure 20. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2017-2022 ($ Millions)
Figure 22. Americas Biopharmaceutical Contract Manufacturing(BCMO) Value Market Share by Country in 2021
Figure 23. Americas Biopharmaceutical Contract Manufacturing(BCMO) Consumption Market Share by Type in 2021
Figure 24. Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application in 2021
Figure 25. United States Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Region in 2021
Figure 30. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application in 2021
Figure 31. China Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Country in 2021
Figure 38. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Type in 2021
Figure 39. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application in 2021
Figure 40. Germany Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size Market Share by Application in 2021
Figure 48. Egypt Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 54. APAC Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 55. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 57. United States Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 58. Canada Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 61. China Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 62. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 63. Korea Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 65. India Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 66. Australia Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 67. Germany Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 68. France Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 69. UK Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 70. Italy Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 71. Russia Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 72. Spain Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 75. Israel Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Biopharmaceutical Contract Manufacturing(BCMO) Market Size 2023-2028 ($ Millions)